Approval No: SFDA approval number H20213668
Specification: 25mg
Packaging/box: 28 tablets
Production enterprise: Hefei Heyuan Pharmaceutical Co., LTD
Mass stratification: New Category 4 (Consistent overassessment)
Medical insurance: Medical insurance class B
Adapt to disease:
Epilepsy